Bartolome Burguera
The Cleveland Clinic · Institute Chairman
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bartolome Burguera as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:01 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06854614 · Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)The Cleveland Clinic · active not recruiting · Obesity · principal investigator
- Ph4NCT04531176 · EMI-EHP Weight Management and Type 2 Diabetes Pragmatic TrialThe Cleveland Clinic · terminated · Type 2 Diabetes, Obesity · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:01 UTC. The ranking covers the 200 most relevant of 21 PubMed records, and a shared surname and initials can bring in a namesake. All 21 on PubMed
- Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.Nat Med · 2024292 citationsRCR 45.5
- 214 citationsRCR 6.0
- 183 citationsRCR 7.7
- Localization of leptin receptor in the human brain.Neuroendocrinology · 1997179 citationsRCR 4.8
- Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man.J Clin Endocrinol Metab · 1990129 citationsRCR 4.9
- Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man.Neuroendocrinology · 1990106 citationsRCR 4.0
- Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.Diabetes Care · 202480 citationsRCR 10.0
- Lipids activate skeletal muscle mitochondrial fission and quality control networks to induce insulin resistance in humans.Metabolism · 202173 citationsRCR 4.3
- 68 citationsRCR 2.5
- Brief report: treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes.N Engl J Med · 199252 citationsRCR 1.6